Back to 
Arrowstreet Capital, Limited Partnership
Arrowstreet Capital, Limited Partnership
AZN
2 quarters
Position history for Arrowstreet Capital, Limited Partnership's holdings in AstraZeneca PLC
Yes. Arrowstreet Capital holds 5,307,020 shares of AZN (AstraZeneca), worth $1B, as of its Q2 2026 13F filing. It increased the position by 654,774 shares (+14.1%) from Q1 2026. Arrowstreet Capital has held AZN in every 13F on record since Q1 2026, 2 quarterly filings. AZN is 0.4% of Arrowstreet Capital's reported 13F portfolio.
Current Value
$1B
Current Shares
5.3M
Total Value Change
+$88M
Total Shares Change
+654,774
Quarter-by-Quarter History
Other major holders of AZN: Vanguard Capital Management LLC, Capital International Investors, Norges Bank